• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Sarnova to Acquire and Simultaneously Combine Digitech and R1 EMS Businesses in Partnership with Pamlico Capital and Digitech Founder & CEO Mark Schiowitz

Share:

July 27, 2020

Sarnova announced today that it will acquire and simultaneously combine Digitech and the R1 RCM Inc. (“R1”) EMS business (formerly ADPI/Intermedix), in partnership with Pamlico Capital and Digitech Founder and CEO Mark Schiowitz, to create a leading provider of revenue cycle management (RCM) solutions for emergency medical services (EMS) professionals. The business will continue to operate under the Digitech name and will be led by Mark Schiowitz and the combined management teams.

Sarnova is a leading national specialty distributor of healthcare products and services for the EMS and acute care markets. Sarnova’s Bound Tree Medical division has been a dedicated servant of the EMS community and committed to its mission “to help those who save and improve patients’ lives” for over 40 years. “We are committed to providing an unparalleled portfolio of products and services to our existing and new EMS customers, and this transaction is a significant demonstration of that commitment,” said Jeff Prestel, CEO of Sarnova. “We invest in companies and capabilities that specifically serve the EMS industry with the best products, services, and support,” said Mark Dougherty, Chief Business Development Officer of Sarnova. “We are excited to support Digitech’s growth through continued investment in its innovative technology platform and expansion of its dedicated team of EMS billing experts.”

Digitech, headquartered in Chappaqua, New York and led by Founder and CEO Mark Schiowitz since 1984, offers comprehensive RCM services and technology solutions focused exclusively on the EMS market. Digitech serves municipalities, hospitals, and private ambulance customers through innovative technology, time-tested processes, and true partnerships with EMS clients. “We are solely dedicated to serving the EMS industry with our billing solutions, and we are excited to serve a wider range of EMS providers with the acquisition of the R1 EMS business,” said Mark Schiowitz. “With investment from Sarnova and Pamlico, we have a unique opportunity to bring two great EMS RCM companies together to further support the success of our current and future customers by maximizing their revenue with superior technology, integration expertise, and transparent real-time reporting.”

“We look forward to partnering with Pamlico Capital, Mark Schiowitz, and the Digitech and Sarnova teams to support Digitech’s next phase of growth and advance Sarnova’s commitment to be the partner of choice for the EMS community,” said Yuriy Prilutskiy, Managing Director at Patricia Industries, a part of Investor AB and majority owner of Sarnova.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Pamlico Capital, an investor in Digitech since 2019, will retain a significant interest in the business alongside Sarnova and Mark Schiowitz. “We are incredibly excited to continue our investment in Digitech and we look forward to helping Digitech, in partnership with Sarnova, increase its presence in the EMS industry and continue to innovate its core offerings,” said Art Roselle, Pamlico Partner.

Sarnova was represented by Robert W. Baird & Co. Inc (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pamlico was advised by Alston and Bird LLP (legal advisor). R1 was advised by Evercore (financial advisor) and Winston & Strawn LLP (legal advisor).

Source: Biospace

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • 3 Major Challenges Plaguing Europe’s Digital Healthcare Efforts3 Major Challenges Plaguing Europe’s Digital Healthcare Efforts
  • CVS Health, UCLA Health Partner to Bolster Hospital Capacity for COVID-19CVS Health, UCLA Health Partner to Bolster Hospital Capacity for COVID-19
  • Mercy Enhances Patient Access and Outreach through Bright.mdMercy Enhances Patient Access and Outreach through Bright.md
  • Takeda Pharmaceutical : Comments on Ongoing Phase 1 Review by the European Commission of the Proposed Acquisition of Shire plcTakeda Pharmaceutical : Comments on Ongoing Phase 1 Review by the European Commission of the Proposed Acquisition of Shire plc
  • How Pharmaceutical Companies can Capture Maximum Value from M&A: Infiniti Research Reveals Key Considerations for Pharma M&A SuccessHow Pharmaceutical Companies can Capture Maximum Value from M&A: Infiniti Research Reveals Key Considerations for Pharma M&A Success
  • Medigene, IRICoR and Université De Montréal Sign Collaboration and Exclusive Licensing Option on Novel Cancer AntigensMedigene, IRICoR and Université De Montréal Sign Collaboration and Exclusive Licensing Option on Novel Cancer Antigens
  • Mapping Variation in Breast Cancer Screening: Where to Intervene?Mapping Variation in Breast Cancer Screening: Where to Intervene?
  • Avista Capital Partners Acquires GCM, A Leading Outsourced Component Manufacturer For The MedTech IndustryAvista Capital Partners Acquires GCM, A Leading Outsourced Component Manufacturer For The MedTech Industry

Trending This Week

  • New tools and acquisitions from OptumRx, ScionHealth.
  • In the wake of Dobbs, women’s health is ‘Ripe for investment’
  • Market Skeptical Following Sen. Warren’s Antitrust Allegations
  • Rogers, Shaw tick lower amid a report that Industry Minister in no hurry to Ok deal
  • ReLive Biotechnologies, Ltd. Completes Asset Purchase of Co.Don AG and Series A Financing Led By SHC, furthering its Ambition to Become the Global Leader in Regenerative Therapies
  • LGM Pharma Acquires Pharmaceutical Development and Manufacturing Unit of Nexgen Pharma

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications